$7.31
Closed
$0.13(1.74%)

At close

About

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Boston, Massachusetts and currently employs 246 full-time employees. The company went IPO on 2020-12-18. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Country

US

CEO

Dr. Kevin Knopp

IPO date

2020

Employees

230

ISIN

US65443P1021

Key stats

Open

$2.78

Volume

4.13M

Market cap

$255.33M

Prev. close

$7.19

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$1.81

52W Range

$7.38

Valuation

61
Valuation score
Undervalued
P/E
-
P/S
2.58
P/B
0.99
Current ratio
7.62
Debt / Equity
-0.50
ROE
-12.60%
Gross margin
47.05%
Income growth
-324.23%
FCF growth
523.84

Analysts estimates

Consensus rating
Buy

The average rating from top 10 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.61
The top 4 analysts forecasts that 12-month price may decrease by 23.26%, with a low of $5.05 and a high of $6.30
$5.05
Low
$5.61
Avg
$6.30
High
Current price

Earnings

Q1 ‘25 revenue
$11.78M
Q1 ‘25 net income
$43.60M
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.18
Actual EPS
Estimate EPS